MVIS US Listed Pharmaceutical 25 Index

The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights (as of latest close) is available below.

Items 1-25 of total 25
ComponentCountryWeight
PFIZER INCUS6.19%
ABBVIE INCUS5.71%
NOVO-NORDISK A/S-SPONS ADRDK5.64%
MERCK & CO. INC.US5.16%
ELI LILLY & COUS5.11%
ZOETIS INCUS5.09%
MCKESSON CORPUS5.06%
ASTRAZENECA PLC-SPONS ADRGB5.04%
SANOFI-ADRFR4.98%
JOHNSON & JOHNSONUS4.92%
GLAXOSMITHKLINE PLC-SPON ADRGB4.86%
NOVARTIS AG-ADRCH4.85%
BRISTOL-MYERS SQUIBB COUS4.60%
AMERISOURCEBERGEN CORPUS4.48%
CATALENT INCUS4.11%
MYLAN NVNL4.00%
TAKEDA PHARM-ADRJP3.76%
TEVA PHARMACEUTICAL-SP ADRIL3.24%
ELANCO ANIMAL HEALTH INCUS3.20%
ORGANON & COUS2.70%
BAUSCH HEALTH COS INCCA2.58%
JAZZ PHARMACEUTICALS PLCIE2.26%
PERRIGO CO PLCIE1.35%
PATTERSON COMPANIES INCUS0.55%
AMARIN CORPORATION PLC -ADRGB0.54%
Items 1-25 of total 25
Up